Natera Inc.

151.20
1.57 (1.05%)
At close: Mar 21, 2025, 3:59 PM
154.06
1.89%
After-hours: Mar 21, 2025, 06:55 PM EDT
1.05%
Bid 145.83
Market Cap 20.44B
Revenue (ttm) 1.75B
Net Income (ttm) -195.89M
EPS (ttm) -1.53
PE Ratio (ttm) -98.82
Forward PE -128.35
Analyst Buy
Ask 157.01
Volume 716,502
Avg. Volume (20D) 1,630,545
Open 149.44
Previous Close 149.63
Day's Range 146.35 - 152.08
52-Week Range 83.13 - 183.00
Beta 1.80

About NTRA

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; a...

Sector Healthcare
IPO Date Jul 1, 2015
Employees 4,424
Stock Exchange NASDAQ
Ticker Symbol NTRA
Full Company Profile

Analyst Forecast

According to 17 analyst ratings, the average rating for NTRA stock is "Buy." The 12-month stock price forecast is $188, which is an increase of 24.34% from the latest price.

Stock Forecasts

Next Earnings Release

Natera Inc. is scheduled to release its earnings on May 8, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+1.58%
Natera shares are trading higher after the company... Unlock content with Pro Subscription
1 month ago
+2.67%
Natera shares are trading higher after the company announced it will reveal new insights and innovations for tissue-free MRD at ASCO GI 2025